Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- Uromedica
- Study ID
- NCT04248283
- Status
- Recruiting
Conditions
- Urinary Incontinence
- Urinary Incontinence,Stress
Eligibility Criteria
- Sex
- FEMALE
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Adjustable Continence Therapy for Women (ACT) — DEVICETwo ACT devices are implanted in each patient. The devices are intended for implantation in the paraurethral space, with the balloons located on each side of the urethra near the bladder neck. The ports are placed subcutaneously in the labia majora. The balloons are filled after implantation with an isotonic solution via needle injection into the port. The ACT implant can be placed using local, spinal or general anesthesia with the surgical instruments (provided separately).
Study Details
A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.
Key Dates
- Start date
- Jan 26, 2021
- Status verified
- Jul 2024
- Primary completion
- Sep 30, 2025
- Completion
- Dec 30, 2025
Study Design
- Enrollment
- 167 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Adjustable Continence Therapy for WomenImplantation of the Adjustable Continence Therapy for the treatment of female SUI.
Primary Outcome Measure
Provocative pad weight [ Time Frame: 12 months ]
Central Contacts
- Patrick Gora763-694-9880
- Timothy C Cook, PhD763-694-9880
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado | Denver | Colorado | 80045 | Andrea Pina Brian Flynn, MD (PRINCIPAL_INVESTIGATOR) Nate Coddington, MD (SUB_INVESTIGATOR) |
| CHI Health Research Center | Omaha | Nebraska | 68124 | Michael Feloney, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Denver, CO
Related Studies
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightPHASE3 · Recruiting · Eli Lilly and Company · Birmingham, Alabama
- Muscle Fiber Fragment Treatment for Urinary IncontinencePHASE1/PHASE2 · Recruiting · Wake Forest University · Winston-Salem, North Carolina
- Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord InjuriesPHASE2 · Recruiting · The University of Texas Medical Branch, Galveston · College Station, Texas
- Feasibility of Triggered Sacral Neuromodulation for Neurogenic BladderRecruiting · VA Office of Research and Development · Cleveland, Ohio